In Vivo News

19 Jul 2018

We all have in mind wonderful speakers, from Steve Jobs to Martin Luther King. The power of a good pitch to make a difference, to mobilise people or resources, is beyond question. For researchers, a good presentation may be the difference between being invited to be member of a consortium or not, between getting funding or not, between receiving an ERC grant or watching the grant go to someone else. On May 14-15, a group of 9 IRB Barcelona researchers (from PhD students to postdocs) participated in a 2-day course to learn about “Pitch Strategies That Get Investors to “YES”!”, organized by the Innovation Department with the support of La Caixa Foundation Young Biomedtec programme...

<p>Ayse Gül Süter, artist in the second year of the "Artist in Residence" Programme at IRB Barcelona</p>
19 Jul 2018

At the beginning of June, the institute opened its doors to IRB Barcelona’s new Artist in Residence Ayşe Gül Süter (1982, Istanbul, Turkey). A former lab is serving as a temporary art studio for Ayse and a peaceful place in which this self-confessed introvert can ponder over what she sees and learns in our labs…a place in which she can let her imagination loose with new tools that can be used to produce artwork.

Ayse completed a degree in Communication Art at Boston University in 2006. She then did several internships with advertising and design companies but felt that this wasn’t her calling. She was awarded a fellowship to train at New York University's Tisch School of the Arts...

19 Jul 2018

Like many other great discoveries made in science, chance played an important role in the last article published in Cancer Cell by a team of researchers from the Signalling and Cell Cycle Laboratory at IRB Barcelona. "I think we were lucky, but we also knew how to take advantage of our luck," says the biochemist Begoña Cánovas, co-first author of the article, together with Ana Igea.

This success story started back in 2011 when Angel R. Nebreda’s Signalling and Cell Cycle Laboratory moved from CNIO (Madrid) to IRB Barcelona. Among many other things (from big machines to tiny gene copies), they brought with them some mice that were about to be discarded. They had been...

27 Abr 2018

Jelena Urosevic (Serbia, 1977) studied Molecular Biology and Physiology at the University of Belgrade in Serbia. After completing an MSc in Biology there, in 2003 she moved to Spain to do her PhD at the Spanish National Cancer Research Centre (acronym CNIO in Spanish), where she focused on the primary tumour. In 2010, she joined IRB Barcelona as a postdoc in the Growth Control and Cancer Metastasis lab.

At the Institute she not only does research on what she is most passionate about, namely the process of metastasis, but also serves as the postdoc representative on the Equality and Diversity Committee. Indeed, as a member of this body, Jelena was involved in the organisation of...

<p>From left to right: Begoña Carreño-Gómez, Javier Garcia, Maria C Freire, Carlos Plata, Eva Méndez and Remi Droller during their visit to IRB Barcelona.</p>
27 Abr 2018

The Business Advisory Board (BAB) visited IRB Barcelona on 3 April. Launched in 2013 and convening every two years, the BAB puts their expertise to the service of the Institute with the aim to speed up technology transfer and map out a successful tech-transfer roadmap.

During the visit, the BAB advised the Innovation Department on the tech transfer strategy for the next three years and gave specific guidance on how to push those innovation projects that are closest to the market. The board was debriefed on several initiatives in the "tech transfer" field, such as the Entrepreneur in Residence Programme, and had an informal meeting with about 20 pre and postdocs. “This session...

27 Abr 2018

Metastasis refers to the spread of cancer from one place in the body to another. This process causes 90% of deaths from cancer, making it one of the most relevant public health challenges today. Cancer is a disease that affects our entire society, and as such, society as a whole must come together to find the cure. It was under this premise that IRB Barcelona, in collaboration with ESADE Business School, brought together key figures from the research, business and innovation, and private sectors to learn about the state of the art in metastasis research, debate the power that business and innovation hold to accelerate cures, and outline future challenges.

"Metastasis...

<p>Tubulin, standard Antibody staining (Credit: C. Hellriegel / Carl Zeiss Microscopy GmbH, Jena)</p>
27 Abr 2018

In research, thorough investigation and detailed information are everything. The difference between a functional and dysfunctional cellular structure can be in the scale of nanometers and being able to perceive this difference can change the way we go about tackling a scientific question. To provide the scientific community with the means to perform microscopy at the highest resolution available, IRB Barcelona has recently invested in state-of-the-art Super Resolution (SR) technology, or Nanoscopy, with the acquisition of a Carl Zeiss Elyra PS1 Airyscan system, which enables 3D SR microscopy and SR for in vivo samples.

The Elyra-Airyscan equipment responds to the...

12 Mar 2018

Horacio Moreno (Barcelona, 1971) recently joined IRB Barcelona’s Innovation Department as the new Entrepreneur in Residence. Launched in 2016, this position aims to foster an entrepreneurial culture in our scientific community by hosting an in-house expert in bio-entrepreneurship for a year. Horacio holds a PhD in Biochemistry and a Master’s in Business Administration. He has has more than 16 years’ experience as a business developer in the biopharma industry, including at companies such as Almirall, Gebro Pharma and Menarini. He currently works as a consultant in business development for biotech companies, and he is also involved in training and teaching programmes at IQS (Institut...

12 Mar 2018

Susana Ros (Barcelona, 1980) did her PhD at IRB Barcelona from 2004 to 2009 in the Metabolic Engineering and Diabetes Group, under the supervision of Dr. Joan Guinovart. After a 4-year postdoc at the Cancer Research UK -London Research Institute, in the Gene Expression Analysis Laboratory, she moved to Cambridge, where she became a Research Associate in imaging cancer metabolism in the Molecular Imaging Laboratory at the Cancer Research UK -Cambridge Research Institute -University of Cambridge. Her research has been focused so far on metabolism and cancer—on understanding the effects of perturbation of metabolic networks in the context of cancer. In this interview, Susana tells us about...

12 Mar 2018

From March until this Spring, five new postdoctoral researchers will be joining the ranks of IRB Barcelona through the PROBIST Programme. This is an international postdoctoral fellowship programme co-funded by the H2020 Marie Sklodowska-Curie Actions COFUND scheme and led by the Barcelona Institute of Science and Technology (BIST), a scientific initiative of seven Catalan research centres.

After passing through a rigorous selection process, five talented researchers have been offered positions and will be joining IRB Barcelona. Ilaria Dutto will work on identifying new candidate genes linked to mitotic fidelity and microcephaly; Aleksandra Karolak will focus on studies of DNA...